Composition for Improving or Preventing Nonalcoholic Fatty Liver
Kohjin Life Sciences Co., Ltd.
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 2 of these applications claim priority to application 16/232,747, filed Dec 26, 2018. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 11,207,371 | Composition for Improving or Preventing Nonalcoholic Fatty Liver In force · High confidence | Kohjin Life Sciences Co., Ltd. | In force | High confidence | ||
| US 11,771,735 | Composition for Improving or Preventing Nonalcoholic Fatty Liver In force · High confidence | Kohjin Life Sciences Co., Ltd. | In force | High confidence | ||
| Application 15/555,901 | Composition for Improving or Preventing Nonalcoholic Fatty Liver Kohjin Life Science Co., Ltd., Public University Corporation Yokohama City University, Kyoto Prefectural Public University Corporation and Saga University Abandoned Abandoned Feb 25, 2019 | Kohjin Life Science Co., Ltd., Public University Corporation Yokohama City University, Kyoto Prefectural Public University Corporation and Saga University | Abandoned | Abandoned Feb 25, 2019 | ||
| Application 16/232,747 | Composition for Improving or Preventing Nonalcoholic Fatty Liver Abandoned Abandoned Jul 21, 2020 | Kohjin Life Sciences Co., Ltd. | Abandoned | Abandoned Jul 21, 2020 |
4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
2 of these are in force and held by Kohjin Life Sciences Co., Ltd..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.